BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29485002)

  • 1. Emerging Roles of Purinergic Signaling in Diabetes.
    Fotino C; Dal Ben D; Adinolfi E
    Med Chem; 2018; 14(5):428-438. PubMed ID: 29485002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ectonucleoside triphosphate diphosphohydrolases and ecto-5'-nucleotidase in purinergic signaling: how the field developed and where we are now.
    Zimmermann H
    Purinergic Signal; 2021 Mar; 17(1):117-125. PubMed ID: 33336318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unfolding Role of a Danger Molecule Adenosine Signaling in Modulation of Microbial Infection and Host Cell Response.
    Lee JS; Yilmaz Ö
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29315226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity.
    Deaglio S; Robson SC
    Adv Pharmacol; 2011; 61():301-32. PubMed ID: 21586363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD39-adenosinergic axis in renal pathophysiology and therapeutics.
    Kishore BK; Robson SC; Dwyer KM
    Purinergic Signal; 2018 Jun; 14(2):109-120. PubMed ID: 29332180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleotidase cascades are catalyzed by secreted proteins of the parasitic nematode Trichinella spiralis.
    Gounaris K
    Infect Immun; 2002 Sep; 70(9):4917-24. PubMed ID: 12183537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATPergic signaling disruption in human sepsis as a potential source of biomarkers for clinical use.
    Leite RO; de Souza PO; Haas CB; da Silveira F; Mohr KR; Bertoni APS; Soares MS; Azambuja JH; Prá MD; da Cruz LLP; Gelsleichter NE; Begnini K; Hasko G; Wink MR; Spanevello RM; Braganhol E
    Clin Exp Med; 2023 Nov; 23(7):3651-3662. PubMed ID: 36943594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Istradefylline modulates purinergic enzymes and reduces malignancy-associated factors in B16F10 melanoma cells.
    da Silva JLG; Viana AR; Passos DF; Krause LMF; Miron VV; Schetinger MRC; Pillat MM; Palma TV; Leal DBR
    Purinergic Signal; 2023 Dec; 19(4):633-650. PubMed ID: 36522571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purinergic signaling in the modulation of redox biology.
    Savio LEB; Leite-Aguiar R; Alves VS; Coutinho-Silva R; Wyse ATS
    Redox Biol; 2021 Nov; 47():102137. PubMed ID: 34563872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Purinergic System Enzymes on Noncommunicable, Neurological, and Degenerative Diseases.
    Bagatini MD; Dos Santos AA; Cardoso AM; Mânica A; Reschke CR; Carvalho FB
    J Immunol Res; 2018; 2018():4892473. PubMed ID: 30159340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purinergic Signaling in Pulmonary Inflammation.
    Le TT; Berg NK; Harting MT; Li X; Eltzschig HK; Yuan X
    Front Immunol; 2019; 10():1633. PubMed ID: 31379836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purinergic signaling as a new mechanism underlying physical exercise benefits: a narrative review.
    Cardoso AM; Silvério MNO; de Oliveira Maciel SFV
    Purinergic Signal; 2021 Dec; 17(4):649-679. PubMed ID: 34590239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intercellular crosstalk shapes purinergic metabolism and signaling in cancer cells.
    Hesse J; Steckel B; Dieterich P; Aydin S; Deussen A; Schrader J
    Cell Rep; 2024 Jan; 43(1):113643. PubMed ID: 38175748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purinergic signaling: decoding its role in COVID-19 pathogenesis and promising treatment strategies.
    Shafaghat Z; Ghomi AK; Khorramdelazad H; Safari E
    Inflammopharmacology; 2023 Dec; 31(6):3005-3020. PubMed ID: 37805959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine and paracrine purinergic signaling in the most lethal types of cancer.
    Reyna-Jeldes M; Díaz-Muñoz M; Madariaga JA; Coddou C; Vázquez-Cuevas FG
    Purinergic Signal; 2021 Sep; 17(3):345-370. PubMed ID: 33982134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purinergic signalling and diabetes.
    Burnstock G; Novak I
    Purinergic Signal; 2013 Sep; 9(3):307-24. PubMed ID: 23546842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophils: fast and furious-the nucleotide pathway.
    Rubenich DS; de Souza PO; Omizzollo N; Lenz GS; Sevigny J; Braganhol E
    Purinergic Signal; 2021 Sep; 17(3):371-383. PubMed ID: 33913070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purinergic signaling and tumor microenvironment in cervical Cancer.
    Pfaffenzeller MS; Franciosi MLM; Cardoso AM
    Purinergic Signal; 2020 Mar; 16(1):123-135. PubMed ID: 32170538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purinergic enzymes on extracellular vesicles: immune modulation on the go.
    Winzer R; Nguyen DH; Schoppmeier F; Cortesi F; Gagliani N; Tolosa E
    Front Immunol; 2024; 15():1362996. PubMed ID: 38426088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From purines to purinergic signalling: molecular functions and human diseases.
    Huang Z; Xie N; Illes P; Di Virgilio F; Ulrich H; Semyanov A; Verkhratsky A; Sperlagh B; Yu SG; Huang C; Tang Y
    Signal Transduct Target Ther; 2021 Apr; 6(1):162. PubMed ID: 33907179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.